PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen.
Saved in:
| Title: | PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen. |
|---|---|
| Authors: | Salem F; Drug Metabolism and Pharmacokinetics, GSK R&D, Gunnels Wood Rd, Stevenage, SG1 2NY, UK. farzaneh.x.salem@gsk.com., Stader F; Certara UK Limited, Simcyp Division, Level 2 Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Youssef AS; Clinical Pharmacology Modeling and Simulation, GSK R&D, Collegeville, Pennsylvania, USA., Derbalah A; Certara UK Limited, Simcyp Division, Level 2 Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK., Nader A; Clinical Pharmacology Modeling and Simulation, GSK R&D, Collegeville, Pennsylvania, USA., Hood S; Drug Metabolism and Pharmacokinetics, GSK R&D, Gunnels Wood Rd, Stevenage, SG1 2NY, UK., Taskar K; Drug Metabolism and Pharmacokinetics, GSK R&D, Gunnels Wood Rd, Stevenage, SG1 2NY, UK. |
| Source: | The AAPS journal [AAPS J] 2026 Mar 13; Vol. 28 (2). Date of Electronic Publication: 2026 Mar 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41826491 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Salem+F%22">Salem F</searchLink>; Drug Metabolism and Pharmacokinetics, GSK R&D, Gunnels Wood Rd, Stevenage, SG1 2NY, UK. farzaneh.x.salem@gsk.com.<br /><searchLink fieldCode="AU" term="%22Stader+F%22">Stader F</searchLink>; Certara UK Limited, Simcyp Division, Level 2 Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Youssef+AS%22">Youssef AS</searchLink>; Clinical Pharmacology Modeling and Simulation, GSK R&D, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Derbalah+A%22">Derbalah A</searchLink>; Certara UK Limited, Simcyp Division, Level 2 Acero, 1 Concourse Way, Sheffield, S1 2BJ, UK.<br /><searchLink fieldCode="AU" term="%22Nader+A%22">Nader A</searchLink>; Clinical Pharmacology Modeling and Simulation, GSK R&D, Collegeville, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Hood+S%22">Hood S</searchLink>; Drug Metabolism and Pharmacokinetics, GSK R&D, Gunnels Wood Rd, Stevenage, SG1 2NY, UK.<br /><searchLink fieldCode="AU" term="%22Taskar+K%22">Taskar K</searchLink>; Drug Metabolism and Pharmacokinetics, GSK R&D, Gunnels Wood Rd, Stevenage, SG1 2NY, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101223209%22">The AAPS journal</searchLink> [AAPS J] 2026 Mar 13; Vol. 28 (2). <i>Date of Electronic Publication: </i>2026 Mar 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+of+Pharmaceutical+Scientists%22">American Association of Pharmaceutical Scientists </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101223209 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1550-7416 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215507416%22">15507416 </searchLink><i>NLM ISO Abbreviation: </i>AAPS J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41826491 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1208/s12248-026-01228-9 Languages: – Code: eng Text: English Titles: – TitleFull: PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salem F – PersonEntity: Name: NameFull: Stader F – PersonEntity: Name: NameFull: Youssef AS – PersonEntity: Name: NameFull: Derbalah A – PersonEntity: Name: NameFull: Nader A – PersonEntity: Name: NameFull: Hood S – PersonEntity: Name: NameFull: Taskar K IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 03 Text: 2026 Mar 13 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1550-7416 Numbering: – Type: volume Value: 28 – Type: issue Value: 2 Titles: – TitleFull: The AAPS journal Type: main |
| ResultId | 1 |